SCOPUS 정보 검색 플랫폼

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 9, 2000, Pages 2572-2574

Use of saliva specimens for monitoring indinavir therapy in human immunodeficiency virus-infected patients

(7) Wintergerst, U a Kurowski, M a Rolinski, B a Muller, M a Wolf, E a Jaeger, H a Belohradsky, B H a

a LUDWIG MAXIMILIANS UNIVERSITY (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; EFAVIRENZ; HYDROXYUREA; INDINAVIR; LAMIVUDINE; NEVIRAPINE; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MONITORING; DRUG SALIVA LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MAXIMUM ALLOWABLE CONCENTRATION; NEPHROLITHIASIS; PRIORITY JOURNAL;

ADULT; DRUG MONITORING; FEASIBILITY STUDIES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MALE; SALIVA;

EID: 0033836180 PISSN: 00664804 EISSN: None Source Type: Journal
DOI: 10.1128/AAC.44.9.2572-2574.2000 Document Type: Article

Times cited : (14)

References (13)

1
- 0033001617
- Indinavir concentrations and antiviral effect
- (1999) Pharmacotherapy , vol.19 , pp. 708-712
- Acosta, E.P.¹ Henry, K.² Baken, L.³ Page, L.M.⁴ Fletcher, C.V.⁵

2
- 0023631059
- Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma
- (1987) Pediatrics , vol.80 , pp. 894-897
- Aviram, M.¹ Tal, A.² Ben-Zvi, Z.³ Gorodischer, R.⁴

3
- 84908219488
- Statistical methods for assessing agreement between two methods of clinical measurement
- (1986) Lancet , vol.1 , pp. 307-310
- Bland, J.M.¹ Altman, D.G.²

4
- 0033583977
- Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: A cohort study
- (1999) Lancet , vol.353 , pp. 2093-2099
- Carr, A.¹ Samaras, K.² Thorisdottir, A.³ Kaufmann, G.R.⁴ Chisholm, D.J.⁵ Cooper, D.A.⁶

5
- 0017836098
- Therapeutic drug monitoring in saliva
- (1978) Clin. Pharmacokinet. , vol.3 , pp. 39-57
- Danhof, M.¹ Breimer, D.D.²

6
- 0032122438
- Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection
- (1998) JAMA , vol.280 , pp. 35-41
- Gulick, R.M.¹ Mellors, J.W.² Havlir, D.³ Eron, J.J.⁴ Gonzalez, C.⁵ McMahon, D.⁶ Jonas, L.⁷ Meibohm, A.⁸ Holder, D.⁹ Schleif, W.A.¹⁰ Condra, J.H.¹¹ Emini, E.A.¹² Isaacs, R.¹³ Chodakewitz, J.A.¹⁴ Richman, D.D.¹⁵

7
- 0442268112
- A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
- (1997) N. Engl. J. Med. , vol.337 , pp. 725-733
- Hammer, S.M.¹ Squires, K.E.² Hughes, M.D.³ Grimes, J.M.⁴ Demeter, L.M.⁵ Currier, J.S.⁶ Eron, J.J.⁷ Feinberg, J.E.⁸ Balfour, H.H.⁹ Deyton, L.R.¹⁰ Chodakewitz, J.A.¹¹ Fischl, M.A.¹²

8
- 0008201467
- PDR generics, 4th ed. Medical Economics Company, Inc., Montvale, N.J.
- (1998)

9
- 0033046403
- Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1
- (1999) J. Infect. Dis. , vol.179 , pp. 1116-1123
- Murphy, R.L.¹ Sommadossi, J.P.² Lamson, M.³ Hall, D.B.⁴ Myers, M.⁵ Dusek, A.⁶

10
- 0017312862
- Salivary phenytoin concentrations in epilepsy and in chronic renal failure
- (1976) Lancet , vol.2 , pp. 384-386
- Reynolds, F.¹ Ziroyanis, P.N.² Jones, N.F.³ Smith, S.E.⁴

11
- 0025769820
- Evaluation of saliva as a specimen for monitoring zidovudine therapy in HIV-infected patients
- (1991) AIDS , vol.5 , pp. 885-888
- Rolinski, B.¹ Wintergerst, U.² Matuschke, A.³ Fuessl, H.⁴ Goebel, F.D.⁵ Roscher, A.A.⁶ Belohradsky, B.H.⁷

12
- 0029872589
- A 24 week open-label phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir)
- (1996) AIDS , vol.10 , pp. 485-492
- Stein, D.S.¹ Fish, D.G.² Billelo, J.A.³ Preston, S.L.⁴ Martineau, G.L.⁵ Drusano, G.L.⁶

13
- 0031942263
- Single-dose pharmacokinetics of indinavir and the effect of food
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 332-338
- Yeh, K.C.¹ Deutsch, P.J.² Haddix, H.³ Hesney, M.⁴ Hoagland, V.⁵ Ju, W.D.⁶ Justice, S.J.⁷ Osborne, B.⁸ Sterret, A.T.⁹ Stone, J.A.¹⁰ Woolf, E.¹¹ Waldman, S.¹²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.